Fractalkine (FKN) is a chemokine able to mediate the initial capture, firm adhesion, and activation of circulating leukocytes. Many tissues express FKN mRNA and FKN expression is increased during inflammatory conditions. To assess a possible involvement in allergic airway disease, we detected serum levels of FKN in a group of patients affected by allergic rhinitis and/or asthma and found high serum levels of FKN in all patients and in only 26% of healthy donors at lower concentrations. The present results underscore the potential role that this chemokine may play in the pathogenesis of respiratory allergic diseases.
ChadaS.RameshR.MhashilkarA.M.2003. Cytokine- and chemokine-based gene therapy for cancer. Curr. Opin. Mol. Ther.5:463.
2.
KunaP.Cytokines in allergic inflammation. 2003Pol. Merkuriusz Lek.14:497.
3.
BajettoA.BonaviaR.BarberoS.SchettiniG.2002. Characterization of chemokines and their receptors in the central nervous system: Physiopathological implications. J. Neurochemistry82:1311.
4.
OliveiraS.H.LukacsN.W.2003. The role of chemokines and chemokine receptors in eosinophil activation during inflammatory allergic reactions. Braz. J. Med. Biol. Res.36:1455.
5.
ImaiT.HieshimaK.HaskellC.BabaM.NagiraM.NishimuraM.KakizakiM.TakagiS.NomiyamaH.SchallT.J.YoshieO.1997. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell91:521.
6.
FongA.M.RobinsonL.A.SteeberD.A.TedderT.F.YoshieO.ImaiT.PatelD.D.1998. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med.188:1413.
7.
BazanJ.F.BaconK.B.HardimanG.WangW.SooK.RossiD.GreavesD.R.ZlotnikA.SchallT.J.1997. New class of membrane-bound chemokine with a CX3C motif. Nature385:640.
8.
RamdinL.PerksB.SheronN.ShuteJ.K.1998. Regulation of Interleukin-8 binding and function by heparin and α2-macroglobulin. Clin. Exp. Allergy28:616.
9.
LeungT.F.WongG.W.KoF.W.LamC.W.FokT.F.2004. Increased macrophage-derived chemokine in exhaled breath condensate and plasma from children with asthma. Clin. Exp. Allergy34:786.
10.
KalayciO.SonnaL.A.WoodruffP.G.CamargoC.A.JrLusterA.D.LillyC.M.2004. Monocyte chemotactic protein-4 (MCP-4; CCL-13): A biomarker of asthma. J. Asthma41:27.
11.
WongB.W.WongD.McManusB.M.2002. Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease. Cardiovasc. Pathol.11:332.
12.
ChenY.M.Hu-TsaiM.I.LinS.L.TsaiT.J.HsiehB.S.2003. Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats. Nephrol. Dial. Transplant.18:2505.
13.
KastenbauerS.KoedelU.WickM.KieseierB.C.HartungH.P.PfisterH.W.2003. CSF and serum levels of solubile fractalkine (CX3CL1) in inflammatory diseases of the nervous system. J. Neuroimmunol.137:210.
14.
BlaschkeS.KoziolekM.SchwarzA.BenohrP.MiddelP.SchwarzG.KummelK.M.MullerG.A.2003. Proinflammatory role of fractalkine (CX3CL1) in rheumatoid arthritis. J. Rheumatol.30:1918.
15.
MorabitoF.MerendinoR.A.PennaG.CuzzolaM.StelitanoC.CalleaV.Di PasqualeG.MinciulloP.L.CangemiS.2005. The CX3C-chemokine fractalkine (CX3XL1) is detectable in serum of B-cell chronic lymphocytic leucemia patients with lymphnode involvement. Acta. Haematol.113:152
16.
RimaniolA.C.TillS.J.GarciaG.CapelF.GodotV.BalabanianK.Durand-GasselinI.VargaE.M.SimonneauG.EmilieD.DurhamS.R.HumbertM.2003. The CX3C chemokine fractalkine in allergic asthma and rhinitis. J. Allergy Clin. Immunol.112:1139.
17.
GangemiS.RuelloA.ArenaA.MinciulloP.PirazzoliA.Di BlasiP.D'AmbrosioF. PurelloMerendinoR.A.2000. In vitro effect of fluticasone propinate on interleukin-8 production by monocytes obtained from patients affected by moderate-severe allergic asthma. Pharmacology66:57.